The Peptide Report
A feature on the quiet rise of peptide nasal sprays inside founder circles — and why the 2pm cognitive crash is finally meeting its match. Inside Clarity & Focus, the doctor-formulated answer reshaping how knowledge workers manage attention.
The second espresso is losing its grip on high-performance culture. A quiet shift toward intranasal NAD+ is changing how finance professionals manage the afternoon energy cliff.
From trading desks to product war rooms, knowledge workers are quietly abandoning their fourth cold brew for something faster and cleaner. Here's what's actually happening at 3 PM in 2026.
The 3 PM crash isn't a willpower problem — it's a mitochondrial signal. Inside the quiet executive movement to rebuild cellular energy from the ground up.
The afternoon crash isn't a caffeine deficiency — it's a cellular one. Inside the quiet shift among Silicon Valley executives toward intranasal NAD+ as a sustainable answer to mid-day fatigue.
An inside look at the quiet shift among Silicon Valley operators who are trading their third coffee for a two-spray afternoon ritual. Here's the science behind why intranasal peptide delivery is reshaping how executives think about cognitive performance.
